Quarterly Statement Of Cash Flows

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7297738

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
16,461,000,000 JPY
-4,252,000,000 JPY
Interest and dividends received
124,000,000 JPY
27,000,000 JPY
Interest paid
-720,000,000 JPY
-399,000,000 JPY
Net cash provided by (used in) operating activities
8,654,000,000 JPY
-4,524,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-11,568,000,000 JPY
-18,047,000,000 JPY
Other, net
-144,000,000 JPY
744,000,000 JPY
Net cash provided by (used in) investing activities
-12,444,000,000 JPY
-17,814,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
16,900,000,000 JPY
25,999,000,000 JPY
Repayments of long-term borrowings
-7,233,000,000 JPY
-3,689,000,000 JPY
Redemption of bonds
-65,000,000 JPY
JPY
Purchase of treasury shares
0 JPY
JPY
Dividends paid
-1,423,000,000 JPY
-1,476,000,000 JPY
Other, net
22,000,000 JPY
-7,000,000 JPY
Net cash provided by (used in) financing activities
14,203,000,000 JPY
21,129,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
971,000,000 JPY
913,000,000 JPY
Net increase (decrease) in cash and cash equivalents
11,384,000,000 JPY
-296,000,000 JPY
Cash and cash equivalents
41,247,000,000 JPY
29,650,000,000 JPY
23,960,000,000 JPY
24,257,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.